Skip to main content
Equibles

GEODE CAPITAL MANAGEMENT, LLC

Position in EVO — Evotec SE

CIK 1214717 BOSTON, MA
Back to EVO Full portfolio

Position in EVO

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$31,561
-$75,534 QoQ
Shares Held
11,272
-14.9% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#19
of 34 holders
Holding Since
Dec 2021
6 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in EVO Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

GEODE CAPITAL MANAGEMENT, LLC holds $4,788,152,578 across 66 Drug Manufacturers - Specialty & Generic names. EVO ranks #62 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ZTS
Zoetis Inc.
 13,289,622 $954,992,236
2 UTHR
UNITED THERAPEUTICS Corp
 996,598 $539,986,694
3 VTRS
Viatris Inc
 32,807,906 $520,989,547
4 TEVA
Teva Pharmaceutical Industries Ltd
 11,607,196 $393,251,799
5 NBIX
Neurocrine Biosciences Inc
 2,138,777 $360,469,474
6 ELAN
Elanco Animal Health Inc
 11,302,057 $278,143,622
7 ALKS
Alkermes plc.
 4,477,876 $234,640,702
8 LNTH
Lantheus Holdings, Inc.
 1,841,367 $204,281,254

All Filings in EVO

Export CSV
6 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $31,561 11,272
2022-12-31 $107,095 13,238
2022-09-30 $116,362 13,238
2022-06-30 $158,591 13,238
2022-03-31 $200,290 13,238
2021-12-31 $303,643 12,785